Law360 Cheat Sheet: Novartis' Fight Over Generic Entresto
By Dani Kass · March 12, 2025, 9:13 PM EDT
Novartis has led a wide-ranging litigation campaign to block generic versions of its bestselling cardiovascular drug Entresto that has involved multidistrict litigation, trips to several circuit courts and cases against the...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login